Perspective Therapeutics (CATX) Other Non-Current Liabilities (2011 - 2026)

Perspective Therapeutics has disclosed Other Non-Current Liabilities across 16 years of filings, most recently posting $437000.0 for Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $437000.0, up 201.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $437000.0 (up 201.38% YoY), and the FY2025 annual result was $386000.0, up 601.82% from the prior year.
• Other Non-Current Liabilities came in at $437000.0 for Q1 2026 at Perspective Therapeutics, up from $386000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $668000.0 in Q3 2023 to a low of $19000.0 in Q2 2024.
• The 5-year median for Other Non-Current Liabilities is $437000.0 (2026), against an average of $418133.3.
• Across the five-year window, Other Non-Current Liabilities tumbled 97.12% in 2024 and surged 1394.74% in 2025, its largest moves.
• Perspective Therapeutics' Other Non-Current Liabilities stood at $657000.0 in 2022, then rose by 1.67% to $668000.0 in 2023, then sank by 91.77% to $55000.0 in 2024, then surged by 601.82% to $386000.0 in 2025, then advanced by 13.21% to $437000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $437000.0 (Q1 2026), $386000.0 (Q4 2025), and $342000.0 (Q3 2025), per Business Quant data.